Free Trial

Canvas Wealth Advisors LLC Cuts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein logo with Medical background

Canvas Wealth Advisors LLC trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 39.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,294 shares of the company's stock after selling 7,312 shares during the quarter. Canvas Wealth Advisors LLC's holdings in Henry Schein were worth $729,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Sanctuary Advisors LLC lifted its position in Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock valued at $294,000 after acquiring an additional 203 shares during the last quarter. Truist Financial Corp purchased a new stake in shares of Henry Schein during the 4th quarter valued at $257,000. K.J. Harrison & Partners Inc lifted its holdings in shares of Henry Schein by 61.1% during the 4th quarter. K.J. Harrison & Partners Inc now owns 29,000 shares of the company's stock valued at $1,988,000 after purchasing an additional 11,000 shares during the last quarter. Oppenheimer Asset Management Inc. acquired a new stake in shares of Henry Schein in the 4th quarter worth $904,000. Finally, Proficio Capital Partners LLC purchased a new position in Henry Schein during the 4th quarter worth $943,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on HSIC. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Barrington Research decreased their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Piper Sandler dropped their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Finally, Wells Fargo & Company cut their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $79.30.

Get Our Latest Stock Report on HSIC

Henry Schein Trading Up 0.5%

Shares of Henry Schein stock opened at $73.15 on Friday. The stock has a market cap of $8.90 billion, a PE ratio of 22.86, a price-to-earnings-growth ratio of 2.35 and a beta of 0.86. The firm has a fifty day moving average price of $69.59 and a 200 day moving average price of $71.24. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business posted $1.10 EPS. The company's revenue was down .1% on a year-over-year basis. Equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines